We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
Cap. Flow
-$1.33B
Cap. Flow %
-3.4%
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$2.28B
2
OTIS icon
Otis Worldwide
OTIS
+$193M
3
BURL icon
Burlington
BURL
+$191M
4
ABBV icon
AbbVie
ABBV
+$178M
5
W icon
Wayfair
W
+$144M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.66B
2
LMT icon
Lockheed Martin
LMT
+$339M
3
JNJ icon
Johnson & Johnson
JNJ
+$262M
4
PFE icon
Pfizer
PFE
+$167M
5
TGT icon
Target
TGT
+$141M

Sector Composition

Rank Sector Weight
1 Technology 21.52%
2 Healthcare 19.78%
3 Consumer Discretionary 13.09%
4 Financials 11.33%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOO
751
Bombardier Recreational Products
DOO
$4.53B
-267,282
Closed -$4.36M
DOW icon
752
Dow Inc
DOW
$21.9B
-853,700
Closed -$25M
DT icon
753
Dynatrace
DT
$13.3B
-200,000
Closed -$4.77M
EME icon
754
Emcor
EME
$36.2B
-146,400
Closed -$8.98M
EMN icon
755
Eastman Chemical
EMN
$8.23B
-142,200
Closed -$6.62M
EQT icon
756
EQT Corp
EQT
$33.5B
-3,366,340
Closed -$23.8M
EMBJ
757
Embraer S.A. ADS
EMBJ
$12.6B
-743,117
Closed -$5.5M
ESPR
758
DELISTED
Esperion Therapeutics
ESPR
-86,484
Closed -$2.73M
ETN icon
759
Eaton
ETN
$170B
-835,939
Closed -$64.9M
EVR icon
760
Evercore
EVR
$12.3B
-35,000
Closed -$1.61M
EXC icon
761
Exelon
EXC
$47B
-1,562,529
Closed -$41M
G icon
762
Genpact
G
$6.07B
-150,000
Closed -$4.38M
GDS icon
763
GDS Holdings
GDS
$6.55B
-200,000
Closed -$11.6M
GILD icon
764
Gilead Sciences
GILD
$168B
-1,112,325
Closed -$83.2M
GMS
765
DELISTED
GMS Inc
GMS
-700,000
Closed -$11M
GPC icon
766
Genuine Parts
GPC
$17.7B
-100,200
Closed -$6.75M
GTX icon
767
Garrett Motion
GTX
$5.71B
-27,919
Closed -$80K
HAE icon
768
Haemonetics
HAE
$3.94B
-250,000
Closed -$24.9M
HOG icon
769
Harley-Davidson
HOG
$2.66B
-171,800
Closed -$3.25M
IRWD icon
770
Ironwood Pharmaceuticals
IRWD
$709M
-1,375,000
Closed -$13.9M
KMT icon
771
Kennametal
KMT
$2.66B
-174,121
Closed -$3.24M
KR icon
772
Kroger
KR
$35.7B
-924,905
Closed -$27.9M
LIVN icon
773
LivaNova
LIVN
$4.69B
-375,000
Closed -$17M
MAS icon
774
Masco
MAS
$14.7B
-1,189,300
Closed -$41.1M
MEI icon
775
Methode Electronics
MEI
$499M
-58,394
Closed -$1.54M

Similar funds

Adage Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.

  • Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
  • Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
  • Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
  • Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
  • Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
  • Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
  • Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.